Patient characteristics | All patients n = 331 |
---|---|
Age, yearsa | 75.4 ± 0.5 |
Male Sex, n (%) | 215 (65.0) |
Risk factors, n (%) | |
Hypertension | 283 (85.5) |
Diabetes mellitus | 103 (31.1) |
Smoker (current or past) | 98 (29.6) |
Dyslipidemia | 158 (47.7) |
Cardiovascular history, n (%) | |
Heart failure | 91 (27.5) |
Coronary artery disease | 110 (33.2) |
Myocardial infarction | 35 (10.6) |
Previous deep vein thrombosis/pulmonary embolism | 34 (10.3) |
Previous ischemic stroke, n (%) | 127 (38.4) |
Previous hemorrhagic event, n (%) | 304 (91.8) |
Hemorrhagic stroke | 100 (30.2) |
Subarachnoid hemorrhage | 10 (3.0) |
Epidural/subdural hematoma | 33 (10.0) |
Ischemic stroke with hemorrhagic transformation | 19 (5.7) |
Gastro-intestinal bleeding | 90 (27.2) |
Spontaneous hematoma | 40 (12.1) |
Other co-morbidities | |
Cirrhosis, n (%) | 13 (3.9) |
Chronic obstructive pulmonary disease, n (%) | 43 (13.0) |
Thyroid dysfunction, n (%) | 69 (20.8) |
Creatinine at admission (µmol/l)b | 99 [80–129] |
Creatinine clearance at admission, mL/minb | 62 [43–78] |
Hemoglobin at admission (g/dl)b | 13 [11.6–14.2] |
CHA2DS2-VASc scorea | 4.5 ± 0.1 |
HAS-BLED scorea | 3.1 ± 0.1 |